Effect of different doses of S-adenosyl-L-methionine (SAMe) on nicotinic acid-induced hyperbilirubinaemia in Gilbert's syndrome

References

• Schreiber A. J., Sutherland E., Simon F. R. Prevention of estradiol (EE) cholestasis by s-adenosyl-l-methionine (SAMe): possible role of phosphotidylcholine (PC). Hepatology 1982; 2: 697, (abstract)
   Google Scholar
• Schreiber A. J., Warren G., Sutherland E., Simon F. R. Enhancement of taurocholate secretory maximum: s-adenosyl-l-methionine (SAM)-induced cytoprotection. Clin Res 1983; 31: 86, A (abstract)
   Google Scholar
• Schreiber A. J., Simon F. R. Estrogen-induced cholestasis: clues to pathogenesis and treatment. Hepatology 1983; 3: 607–13
   PubMed Web of Science ®Google Scholar
• Stramentinoli G., Di Padova C., Gualano M., Rovagnati P., Galli-Kienle M. Ethynylestradiol-induced impairment of bile secretion in the rat: protective effects of S-adenosyl-l-methionine and its implication in estrogen metabolism. Gastroenterology 1981; 80: 154–8
   PubMed Web of Science ®Google Scholar
• Boelsterli U. A., Rakhit G., Balasz T. Modulation by S-adenosyl-l-methionine of hepatic Na+, K+-ATPase, membrane fluidity, and bile flow in rats with ethynylestradiol-induced cholestasis. Hepatology 1983; 3: 12–7
   PubMed Web of Science ®Google Scholar
• Frezza M., Pozzato G., Chiesa L., Stramentinoli G., Di Padova C. Reversal of intrahepatic cholestasis of pregnancy in women after high dose s-adenosyl-l-methionine administration. Hepatology 1984; 4: 274–8
   PubMed Web of Science ®Google Scholar
• Frezza M., Cammareri G., Di Padova C. Beneficial effects of S-adenosylmethionine in pregnant women with cholestasis: results of a multicenter controlled clinical trial. J Hepatol 1987; 5: 27, (abstract)
   PubMedGoogle Scholar
• Hcikel T. AJ, Lathe G. H. The effect of oral contraceptive steroids on bile secretion and bilirubin Tm in rats. Br J Pharm 1970; 38: 593–601
   PubMedGoogle Scholar
• Combes B., Shibata H., Adams R., Mitchell B. D., Trammell V. Alterations in sulfobromophthalein sodium-removal mechanisms from blood during normal pregnancy. J Clin Invest 1963; 42: 1431–42
   PubMed Web of Science ®Google Scholar
• Muller M. N., Kappas A. Estrogen pharmacology. I. The influence of estradiol and estriol on hepatic disposal of sulfobromophthalein (BSP) in man. J Clin Invest 1964; 43: 1905–14
   PubMedGoogle Scholar
• Simon F. R., Arias I. M. Alteration of bile canalicular enzymes in cholestasis. A possible cause of bile failure. J Clin Invest 1973; 52: 765–75
   PubMedGoogle Scholar
• Simon F. R., Gonzalez M., Sutherland E., Accatino L., Davis R. A. Reversal of ethynyl estradiol-induced bile secretory failure with Triton WR-1339. J Clin Invest 1980; 65: 851–60
   PubMedGoogle Scholar
• Gilbert A., Lereboullet P. La cholemie simple familiare. Sem Med 1901; 21: 231–45
   Google Scholar
• Billing B. M., Williams R., Richards T. G. Defect in hepatic transport of bilirubin in congenital hyperbilirubinemia. An analysis of plasma bilirubin disappearance curves. Clin Sci 1964; 27: 245–57
   PubMedGoogle Scholar
• Gentile S., Saponara A., Foglia F., Grigni N., Garofano M. L., Porcellini M., Coltorti M. Impaired plasma clearance of nicotinic acid and interference with rifamycin-SV in Gilbert's syndrome. A defect of hepatic uptake of organic anions? Ital J Gastroenterol 1981; 13: 94–9
   Google Scholar
• Gentile S., Orzes N., Persico M., Bronzino P., Tiribelli C. Comparison of nicotinic acid and caloric-restriction induced hyperbilirubinemia in the diagnosis of Gilbert's syndrome. J Hepatol 1985; 1: 537–43
   PubMedGoogle Scholar
• Okolicsany L., Fevery J., Billing B., Thompson R. PH, Schmilt R., Berk P. D. How should mild isolated unconjugated hyperbilirubinemia be investigated. Sem Liv Dis 1983; 3: 36–41
   PubMedGoogle Scholar
• Carlson L. A. Determination of free nicotinic acid in blood plasma. Clin Chem Acta 1966; 13: 349–51
   PubMedGoogle Scholar
• Michaelsson M., Nosslin B., Sjolin S. Plasma bilirubin determination in the newborn infant. Pediatrics 1965; 35: 925–31
   PubMed Web of Science ®Google Scholar
• Blankaert N. Analysis of bilirubin and bilirubin mono- and diconjugates. Determination of their relative amounts in biological samples. Biochem J 1980; 185: 115–28
   PubMedGoogle Scholar
• Fromke L. F., Miller D. Constitutional hepatic dysfunction (CHD; Gilbert's disease). A review with special references to a characteristic increase and prolongation of the hyperbilirubinemic response to nicotinic acid. Medicine 1972; 51: 451–73
   PubMedGoogle Scholar
• Gentile S., Tiribelli C., Persico M., Bronzino P., Marmo R., Orzes N., Orlando C., Rubba P., Coltorti M. Dose dependence of nicotinic acid-induced hyperbilirubinemia and its dissociation from hemolysis in Gilbert's syndrome. J Lab Clin Med 1986; 107: 166–71
   PubMed Web of Science ®Google Scholar
• Black M., Billing B. Hepatic bilirubin UDP-Glycuronyltransferase activity in liver disease and Gilbert's syndrome. New Engl Med 1969; 280: 1266–86
   PubMed Web of Science ®Google Scholar
• Fumagalli R. Pharmakinetics of nicotinic acid and some of its derivatives. Metabolic Effect of Nicotinic Acid and its Derivatives, KF Gay, L. A. Carlson. Huber, Bern 1971; 33–48
   Google Scholar
• Sottocasa G. L., Tiribelli C., Luciani M., Lunazzi G. C., Gazzin B. Isolation and some properties of a molecule involved in hepatic bilirubin- and other organic anion-transport. Function and Molecular Aspects of Biomembrane Transport, E. Quagliariello, F. Palmieri, S. Papa, M. Klingerberg. Elsevier-North Holland, Amsterdam 1979; 451–62
   Google Scholar
• Roellingoff W., Paumgartner G., Preisig. Nicotinic acid test in the diagnosis of Gilbert's syndrome: correlation with bilirubin clearance. Gut 1981; 22: 663–8
   PubMedGoogle Scholar
• Gentile S., Tiribelli C., Baldini G., Lunazzi G. C., Sottacasa G. L. Sex differences of nicotinate-induced hyperbilirubinemia in Gilbert's syndrome. Implication of Bilitranslocase function. J Hepatol 1985; 1: 417–29
   PubMedGoogle Scholar
• Berk P. D., Bloomer J. R., Have R. B., Berlin N. I. Constitutional hepatic dysfunction (Gilbert's syndrome): a new definition based on kinetic studies with unconjugated radiobilirubin. Am J Med 1970; 49: 296–301
   PubMed Web of Science ®Google Scholar
• Bombardieri G., Milani A., Bernardi L., Rossi L. Effects of S-adenosyl-l-methionine (SAMe) in the treatment of Gilbert's syndrome. Curr Therap Res 1985; 37: 580–85
   Google Scholar
• Feo F., Pascale R., Garcea R., Daino L., Pirisi L., Frassetto S., Ruggiu M. E., Di Padova C., Stramentinoli G. Effect of the variation of S-adnosyl-l-methionine liver content on fat accumulation and ethanol metabolism in ethanol-intoxicated rats. Toxical Appl Pharmacol 1986; 83: 331–41
   PubMed Web of Science ®Google Scholar
• Di Padova C., Di Padova F., Tritapepe R., Stramentinoli G. S-adenosyl-l-methionine protection against α-naphthyl-isothiocyanate-induced cholestasis in the rat. Toxicol Lett 1985; 29: 131–6
   PubMedGoogle Scholar
• Osada J., Aylagas H., Sanchez-Vegazo I., Gea T., Millan I., Palacios-Alaiz E. Effect of S-adenosyl-l-methionine on thioacetamide-induced liver damage in rats. Toxicol Lett 1986; 32: 97–106
   PubMedGoogle Scholar